glycemia

Related by string. Glycemia * * postprandial glycemia *

Related by context. All words. (Click for frequent words.) 75 postprandial glucose 74 glycosylated hemoglobin HbA1c 73 serum uric acid 73 HbA 1c 72 plasma glucose 72 blood glucose concentrations 71 serum potassium 70 triacylglycerol concentrations 70 hyperglycaemia 70 serum urate levels 70 glycated hemoglobin levels 70 metabolic parameters 70 serum urate 70 serum phosphate 70 lipid levels 70 antihypertensive therapy 70 hemoglobin A1c levels 70 serum cholesterol 70 fasting glucose levels 69 Hb A1C 69 plasma triglycerides 69 serum glucose 69 platelet inhibition 69 adiponectin levels 69 fasting plasma glucose 69 glomerular filtration 69 hemoglobin A1c HbA1c 69 nocturnal hypoglycaemia 69 HbA 1c levels 69 serum cortisol 68 Fasting glucose 68 tHcy 68 atherogenic dyslipidemia 68 plasma glucose levels 68 microvascular complications 68 glycated hemoglobin 68 urate levels 68 HbA1c levels 68 lipid profiles 68 fasting insulin 68 glycaemia 68 endothelial function 68 HbA1C 68 leukocyte count 68 pulmonary arterial 68 glycemic control 68 hemoglobin A1C 67 serum PTH 67 serum phosphate levels 67 serum homocysteine 67 serum triglycerides 67 glucose tolerance 67 postprandial insulin 67 plasma lipid 67 CLA supplementation 67 elevated uric acid 67 urinary albumin 67 homocysteine concentrations 67 postprandial glycemia 67 urinary oxalate 67 baseline HbA1c 66 triglyceride concentrations 66 serum concentrations 66 albumin excretion 66 alanine aminotransferase ALT 66 serum calcium 66 OGTT 66 lowering blood glucose 66 pharmacokinetic PK profile 66 fasting triglycerides 66 serum lipid levels 66 dietary modification 66 urinary excretion 66 glucose homeostasis 66 platelet reactivity 66 AST ALT 66 magnesium intake 66 thyrotropin 66 alanine aminotransferase 66 serum ALT 66 serum sodium 66 serum creatinine levels 66 serum triglyceride levels 66 #.#mmol L [002] 66 adrenal function 66 plasma cortisol 66 dietary intakes 66 flow mediated dilation 66 CVD mortality 66 glycosylated hemoglobin levels 66 serum LDL cholesterol 66 serum vitamin D 66 serum lipid 66 glycosylated hemoglobin 66 intima media thickness 65 antihypertensive medications 65 Hemoglobin A1c 65 plasma lipids 65 plasma leptin 65 triacylglycerol 65 salivary cortisol 65 postprandial blood glucose 65 HbA1C levels 65 serum lipids 65 albuminuria 65 albumin excretion rate 65 elevated homocysteine 65 blood lipids 65 insulin sensitivity 65 glucose lowering 65 HDL C 65 arterial stiffness 65 T2DM 65 abdominal adiposity 65 iPTH 65 Lp PLA 2 65 carotid IMT 65 nonfasting triglycerides 65 apolipoprotein B 65 elevated creatinine 65 NPH insulin 65 hyperinsulinemia 65 elevated LDL cholesterol 65 antioxidant supplementation 65 A1c levels 65 hepatic glucose production 65 serum IGF 65 serum phosphorus 65 lispro 64 urinary calcium 64 HOMA IR 64 urinary albumin excretion 64 serum calcium levels 64 proteinuria 64 fasting plasma glucose FPG 64 colorectal adenoma 64 calcium supplementation 64 cardiac autonomic 64 insulin detemir 64 RBP4 64 normotensive 64 antitumor efficacy 64 dietary calcium intake 64 plasma homocysteine 64 nonfasting triglyceride levels 64 serum parathyroid hormone 64 virological response 64 glycemic variability 64 cardiovascular morbidity 64 fasting plasma 64 uric acid levels 64 glycated hemoglobin HbA1c 64 hemoglobin A1c 64 intact parathyroid hormone 64 diastolic function 64 nondiabetic patients 64 hypoglycemic episodes 64 dietary sodium 64 hemoglobin Hb 64 μmol L 64 neutrophil counts 64 serum leptin 64 fetuin 64 Stop Hypertension DASH diet 64 selenium intake 64 tolvaptan 64 fasting blood glucose 64 cardiometabolic risk 64 subclinical hypothyroidism 64 hsCRP levels 64 paricalcitol 64 QTc intervals 64 bone resorption 64 lowers blood glucose 64 aminotransferases 64 improves glycemic 64 Fasting plasma glucose 64 serum insulin 63 sUA 63 atherogenic 63 plasma renin activity 63 serum ferritin 63 extrapyramidal symptoms 63 platelet activation 63 fasting glucose 63 mmol l 63 periprocedural 63 β blockers 63 IGFBP 63 blood glucose levels 63 transaminase levels 63 neurodevelopmental outcome 63 aspartate aminotransferase 63 lactate dehydrogenase LDH 63 neurodevelopmental outcomes 63 coadministration 63 serum TSH 63 nonfasting 63 virologic response 63 LDL cholesterol lowering 63 lipid parameters 63 density lipoprotein HDL cholesterol 63 fructosamine 63 muscle protein synthesis 63 troponin T 63 apolipoproteins 63 HbA1c 63 blood Phe levels 63 #/#mmHg 63 transaminases 63 A1C levels 63 atherogenic lipids 63 hyperglycemia 63 arterial stiffening 63 liver histology 63 cortisol secretion 63 postoperative mortality 63 LDL cholesterol concentrations 63 leukocyte counts 63 Hypoglycaemia 63 CPAP adherence 63 hypertensive patients 63 HBeAg seroconversion 63 transferrin saturation 63 lumbar spine BMD 62 endothelial activation 62 serum potassium levels 62 glucose concentrations 62 fat oxidation 62 hydroxyvitamin D levels 62 serum phosphorous 62 nondiabetics 62 VADT 62 #mmHg [001] 62 glomerular filtration rate 62 D dimer 62 lymphocyte counts 62 systolic hypertension 62 macroalbuminuria 62 cardiorespiratory fitness 62 GH secretion 62 IFN beta 62 serum testosterone 62 HER2 expression 62 elevated triglycerides 62 triglyceride concentration 62 lipoprotein levels 62 mRNA expression 62 inflammatory biomarkers 62 procalcitonin 62 elevated triglyceride levels 62 pulmonary capillary wedge 62 anti Xa 62 STRIDE PD 62 leptin deficient mice 62 remnant lipoproteins 62 thyroxine 62 microalbuminuria 62 intensive statin therapy 62 HbA 1C 62 dose statin therapy 62 inflammatory markers 62 aspartate aminotransferase AST 62 baroreflex sensitivity 62 clinically meaningful reductions 62 serum retinol 62 vasodilatation 62 pharmacokinetic parameters 62 dose titration 62 detemir 62 hemodilution 62 growth hormone secretion 62 lowering LDL cholesterol 62 autoregulation 62 reflux symptoms 62 pharmacodynamic effects 62 VLDL cholesterol 62 thyroid stimulating hormone 62 triglyceride levels 62 antidiabetic therapy 62 tertiles 62 lipid lowering therapy 62 LDL cholesterol levels 62 adiposity 62 hs CRP 62 intermittent hypoxia 62 dietary carbohydrate 62 umol L 62 autoantibody levels 62 fructose diet 62 fasting triglyceride levels 62 Lp PLA2 62 cystatin C 62 mineral density 62 biphasic insulin aspart 62 serum phosphorus levels 62 airway hyper responsiveness 62 folate intake 62 nondiabetic 62 hypertensives 62 HIV RNA 62 tirofiban 62 TNFalpha 62 Hb A1c 62 Triglyceride levels 62 creatinine levels 62 PSADT 62 total cholesterol triglycerides 62 hepatic function 62 intestinal permeability 61 osmolality 61 PTH secretion 61 insulin degludec 61 hepatic insulin sensitivity 61 systolic BP 61 severe hypoglycemia 61 prolactin levels 61 Calcium intake 61 CK MB 61 baroreceptor 61 C reactive protein 61 arterial elasticity 61 ml kg 61 Endothelial function 61 hippocampal volume 61 creatine kinase 61 insulin sensitizing 61 T1DM 61 timepoints 61 RBP4 levels 61 peripheral insulin sensitivity 61 IDDM 61 cardio respiratory fitness 61 plasma folate 61 intermittent dosing 61 elevated serum creatinine 61 LDL lowering 61 serum PSA 61 baroreflex 61 LDL Cholesterol 61 #mg/dL [001] 61 Serum creatinine 61 antitumor effect 61 adenoma recurrence 61 serum estradiol 61 plasma creatinine 61 renal function 61 lowering systolic blood 61 hemoglobin concentrations 61 plasma glucose concentrations 61 nonpharmacologic 61 protein excretion 61 salivary flow 61 peak VO2 61 thyroid hormone levels 61 infarct size 61 mm Hg systolic 61 metabolic acidosis 61 urine albumin 61 LDL C 61 adiponectin concentrations 61 sodium excretion 61 elevated blood glucose 61 LDL HDL ratio 61 overt nephropathy 61 locomotor activity 61 glycemic load 61 plasma fibrinogen 61 MetS 61 Proteinuria 61 glucagon secretion 61 LDL HDL 61 left ventricular diastolic 61 inotropic 61 total cholesterol LDL 61 elevated ALT 61 interleukin IL -6 61 serum HBV DNA 61 cardiovascular mortality 61 thiazide diuretics 61 creatine supplementation 61 8 OHdG 61 elevated fasting glucose 61 Cmax 61 catabolism 61 oral glucose tolerance 61 glucose insulin 61 primary aldosteronism 61 p# activation 61 HPA axis 61 inducible nitric oxide synthase 61 pCR 61 myocardial reperfusion 61 plasma concentrations 61 density lipoprotein cholesterol 61 oxidized LDL 61 serum GGT 61 virological failure 61 airway hyperresponsiveness 61 tissue oxygenation 61 antibody titer 61 cytopenias 61 triiodothyronine 61 lipid abnormalities 61 eosinophil count 61 macrovascular 61 MMSE scores 61 Pioglitazone 61 Insulin sensitivity 60 dietary folate 60 isoproterenol 60 brachial blood 60 serum magnesium 60 pyridostigmine 60 gallstone disease 60 K DOQI 60 glucocorticoid 60 systolic dysfunction 60 HDL Cholesterol 60 Sgk1 60 plasma uric acid 60 insulin resistance 60 hematologic toxicity 60 macrophage infiltration 60 bronchodilation 60 carotid atherosclerosis 60 visceral adiposity 60 proinflammatory cytokine 60 postoperative AF 60 hypoglycemia unawareness 60 mg/m2 dose 60 atherogenesis 60 gastric emptying 60 metabolite concentrations 60 olmesartan 60 E selectin 60 cholesterols 60 leptin concentrations 60 IGFBP 3 60 apo B 60 daunorubicin 60 virologic 60 blood Phe 60 HDL LDL 60 hemoglobin concentration 60 serum BDNF 60 FOSRENOL ® 60 CTAP# Capsules 60 isoprostane 60 endothelium dependent 60 metabolic abnormalities 60 postprandial glucose levels 60 bezafibrate 60 distensibility 60 Insulin detemir 60 nephrotoxicity 60 calculated creatinine clearance 60 statin monotherapy 60 hypercholesterolaemia 60 cholesterol LDL C 60 μg kg 60 #mg/day [002] 60 pressure natriuresis 60 nitrotyrosine 60 artery stenosis 60 c reactive protein 60 residual confounding 60 PCWP 60 plasma lipoprotein 60 pharmacodynamic parameters 60 posttreatment 60 ALT AST 60 SGPT 60 serum bicarbonate 60 serum albumin 60 serum folate concentrations 60 Stop Hypertension diet 60 lumbar spine bone 60 hyperphosphatemia 60 capillary density 60 Hb levels 60 plasma homocysteine levels 60 serum bilirubin 60 glycemic 60 hsCRP 60 airway inflammation 60 hepatic fibrosis 60 hypercholesterolemia 60 remyelination 60 thromboembolic 60 corrected QT interval 60 nmol l 60 dapagliflozin plus 60 PUFA intake 60 creatinine ratio 60 candesartan 60 impaired endothelial 60 subclinical atherosclerosis 60 symptomatic VTE 60 isolated systolic hypertension 60 incretin 60 peptide BNP 60 catecholamine 60 diastolic BP 60 paraprotein 60 Serum calcium 60 teriflunomide 60 carbohydrate diets 60 vascular reactivity 60 aminotransferase ALT 60 μg liter 60 hepatic cirrhosis 60 proliferative diabetic retinopathy 60 sulfasalazine 60 cardiac biomarkers 60 UACR 60 clinically meaningful improvement 60 pharmacologic intervention 60 antihypertensive drugs 60 QTc prolongation 60 tiotropium 60 aldosterone hormone 60 platelet aggregation 60 oral antidiabetic medication 60 serum selenium 60 serum clusterin levels 60 #OHD levels 60 neurologic outcomes 60 cinacalcet 60 LDL triglycerides 60 #mg/dL [002] 60 airway responsiveness 60 metabolic syndrome MetS 60 hypophosphatemia 60 EDARBI 60 testosterone supplementation 60 APTIVUS r 60 aldosterone 60 atheroma volume 60 creatine phosphokinase 60 DASH diet 60 autonomic dysfunction 60 dyslipidaemia 60 systolic blood pressure 59 intracranial hemorrhage ICH 59 hypertonic saline 59 magnesium supplementation 59 aminotransferase levels 59 trans palmitoleic acid 59 insulin secretion 59 Apidra ® 59 MADRS score 59 NATRECOR R 59 tHcy concentrations 59 overt hypothyroidism 59 irbesartan 59 CYP#D# 59 deferasirox 59 IV bisphosphonates 59 ApoB 59 CD4 + cell 59 posttransplant 59 vasodilation 59 systemic inflammation 59 PYY 59 SERCA2a 59 polyp recurrence 59 virologic failure 59 Subgroup analysis 59 ACh 59 macrovascular events 59 glulisine 59 endothelial dysfunction 59 triacylglycerols 59 sitosterol 59 #OHD 59 lactate dehydrogenase 59 improves insulin sensitivity 59 peptide YY 59 perioperative morbidity 59 baseline LDH 59 dose proportionality 59 arteriolar 59 IFN α 59 CrCl 59 sweat chloride 59 transaminase elevations 59 dietary supplementation 59 myocardial uptake 59 hepatic enzymes 59 neurocognitive function 59 riociguat 59 carbohydrate restriction 59 hematologic parameters 59 baroreceptor reflex 59 malondialdehyde MDA 59 fibrinolysis 59 intraocular pressure IOP 59 nicardipine 59 macrovascular disease 59 hypoglycemic events 59 serum HCV RNA 59 triglyceride TG 59 subclinical inflammation 59 serum folate 59 serum sodium levels 59 SCr 59 androgen suppression 59 pulmonary exacerbations 59 viral kinetics 59 PAOD 59 arterial inflammation 59 IL 1ß 59 fatty acid oxidation 59 transgene expression 59 -#.# mg dL [002] 59 orthostatic 59 Primary endpoints 59 natriuretic peptides 59 posaconazole 59 gastric pH 59 creatinine clearance 59 cerebral infarction 59 hematological parameters 59 diastolic hypertension 59 vessel dilation 59 urinary cortisol 59 selenium supplementation 59 thiazide 59 antiviral efficacy 59 sUA levels 59 #.#mg/dL 59 microglial activation 59 oral antidiabetic medications 59 #mg dose [001] 59 rCBF 59 cTnI 59 urinary N telopeptide 59 exhaled nitric oxide 59 somatostatin analogs 59 recurrent VTE 59 PANSS scores 59 hematological toxicity 59 N telopeptide 59 mean serum phosphorus 59 IFN gamma 59 loop diuretics 59 pramlintide 59 glucose uptake 59 sub maximal 59 blood glucose 59 L lysine 59 Akt activation 59 parathyroid hormone PTH 59 urinary protein 59 left ventricular systolic 59 fasting serum 59 dietary DHA 59 mucosal healing 59 coronary stenosis 59 post prandial glucose 59 residual platelet reactivity 59 cirrhotic patients 59 eNO 59 HuR 59 Ramipril 59 hyperphenylalaninemia HPA due 59 ventricular enlargement 59 sulphonylurea 59 mEq L 59 dose proportional pharmacokinetics 59 cortisol concentrations 59 BENICAR HCT 59 glycemic diet 59 platelet function 59 beta blocker therapy 59 hypertensive rats 59 foveal thickness 59 agonist induced 59 mmHg diastolic 59 Homocysteine 59 cholesterol triglycerides 59 FOLPI 59 mg kg dose 59 Hcy 59 mL/min/#.# m 2 59 hypercalciuria 59 corticosteroid dose 59 cystatin 59 isoenzyme 59 silent myocardial ischemia 59 PaO 2 59 plasma renin 59 hemorrhagic complications 59 cerebral oxygenation 59 lipoprotein 59 intracerebral haemorrhage 59 RYGB 59 TNF antagonist 59 zinc supplementation 59 stone formers 59 macronutrient intake 59 vasopressor 59 NT proBNP 59 ergocalciferol 59 maximally tolerated doses 59 potassium excretion 59 Hypotension 59 dysglycemia 59 glucocorticoid hormones 59 mIU L 59 HDL cholesterol triglycerides 59 #.#mmHg 59 submaximal 59 p = .# [002] 59 immunosuppressive regimen 59 Diastolic pressure 59 NYHA functional class 59 #.#/#.# mmHg [001] 59 homocysteine levels 59 QTcF 59 ghrelin concentrations 59 lymphocyte count 59 left ventricular dysfunction 59 lowering homocysteine 59 Cystatin C 59 NIHSS score 58 eplerenone 58 acromegalic patients 58 pramlintide metreleptin combination 58 fasting hyperglycemia 58 OADs 58 dose dependently 58 bad cholesterol LDL 58 corticosteroid therapy 58 carbohydrate oxidation 58 vascular dysfunction 58 IL 1β 58 skeletal muscle mass 58 #mg dose [002] 58 CsA 58 trans palmitoleate 58 p = #.# [003] 58 pentoxifylline 58 dose atorvastatin 58 dose cytarabine 58 #mmHg [002] 58 concomitant medications 58 insulin lispro 58 pg mL 58 ß carotene 58 desvenlafaxine succinate 58 fatty acid metabolism 58 prostate cancer CaP 58 impaired glucose metabolism 58 thyrotropin levels 58 intermittent claudication 58 FDG uptake 58 Subgroup analyzes 58 SGOT 58 hepatic steatosis 58 intravenous dosing 58 glargine 58 antidepressant efficacy 58 osteocalcin 58 IBS symptoms 58 antiangiogenic therapy 58 ulcer healing 58 fructose intake 58 atherosclerotic disease 58 lipoprotein metabolism 58 myeloperoxidase 58 chromium supplementation 58 losartan 58 isoflavone intake 58 aminotransferase 58 pharmacokinetic characteristics 58 LVEF 58 dietary intake 58 penetrance 58 mixed hyperlipidemia 58 ALLHAT 58 Insulin PH# 58 CIMZIA TM 58 pressor response 58 metabolic disturbances 58 d dimer 58 elevated cortisol 58 diabetic rats 58 morphometric vertebral fractures 58 plasminogen activators 58 vWF 58 rapid virological response 58 mmHg 58 tumor perfusion 58 statin therapy 58 clomipramine 58 ULORIC 58 postintervention 58 carotid bruit 58 glycogen metabolism 58 tocopherol 58 CYP #A# 58 binary restenosis 58 radiographic progression 58 Prehypertension 58 coagulopathy 58 lowest tertile 58 DCCT 58 anticoagulation 58 detrusor 58 arterial thickening 58 lipoprotein Lp 58 metformin monotherapy 58 vildagliptin 58 incretin hormones 58 hypoxemia 58 Ghrelin 58 ursodeoxycholic acid 58 ATACAND 58 gastric acidity 58 inhibin 58 CLA isomers 58 hypokalemia 58 t# c# CLA 58 erythrocyte sedimentation rate 58 elevated IOP 58 parasympathetic tone 58 International Normalized Ratio 58 allopurinol 58 cranial irradiation 58 contrast induced nephropathy 58 ejection fractions 58 carbohydrate metabolism 58 muscarinic 58 atazanavir ritonavir 58 dosing frequency 58 chlorthalidone 58 unmeasured confounders 58 tertile 58 hypoperfusion 58 lowering triglycerides 58 neurodevelopmental impairment 58 endocannabinoid signaling 58 CD# upregulation 58 postoperative morbidity 58 estimated GFR 58 ACE inhibitor ramipril 58 malabsorption 58 calcium homeostasis 58 -#.# ± [002] 58 highest tertile 58 Complications Trial 58 QTc 58 SHBG 58 TMC# r 58 HAART regimens 58 hyperkalemia 58 depressive symptomatology 58 tau phosphorylation 58 DHA supplementation 58 diastolic pressures 58 COPD exacerbations 58 nondepressed 58 #mg/day [001] 58 amyloid β 58 diabetes mellitus DM 58 angiotensin II receptor blockers 58 fat vegan diet 58 telomere lengths 58 carbohydrate absorption 58 corticosterone 58 severe hypoglycaemia 58 metformin sulphonylurea 58 Diastolic 58 exploratory endpoints 58 Elevated serum 58 spirometric 58 postprandial hyperglycemia 58 dosage regimens 58 inecalcitol 58 density lipoprotein cholesterol HDL 58 ApoA1 58 urine NGAL 58 left ventricular LV 58 MDRD 58 Pharmacokinetic parameters 58 CC genotype 58 serum biomarkers 58 decitabine 58 serotonin synthesis 58 orthostatic hypotension 58 systolic function 58 warfarin therapy 58 induced hypoglycemia 58 exogenous insulin 58 coronary calcification 58 NNT = 58 Fasting blood glucose 58 virological suppression 58 CK # plasma concentrations 58 myocardial ischemia 58 Cardiorespiratory fitness 58 NT proBNP concentrations 58 gliclazide 58 sulphonylureas 58 triglycerides 58 thyroglobulin 58 elevated CRP 58 cardiac toxicity 58 probiotic supplementation 58 APTIVUS 58 glucose 58 serum aminotransferase levels 58 calcitriol 58 nonvertebral fracture 58 fosamprenavir 58 myopathy rhabdomyolysis 58 baseline serum creatinine 58 coinfected patients 58 VEGF expression 58 arachidonic acid AA 58 plasma pharmacokinetics 58 dose ritonavir 58 systolic diastolic 58 reinfarction 58 circulating lymphocytes 58 mmol L 58 antidiabetic drugs 58 homozygotes 58 CaPre ™ 58 Pharmacokinetic 58 pharmacologic 58 serum triglyceride 58 hour bronchodilation 58 Ceplene/IL-2 58 KDOQI 58 #mg/dl 58 subcutaneous insulin 58 potassium supplementation 58 Combination therapy 58 dose clopidogrel 58 rate variability HRV 58 fibrosis progression 58 LPS induced 58 recurrent venous thromboembolism 58 acetabular dysplasia 58 QTc interval 58 HDL cholesterol 58 Logistic regression analysis 58 neurologic progression 58 AZOR 58 ACE Inhibitor 58 HAQ DI 57 cerebral perfusion 57 pharmacodynamic PD 57 hydroxy vitamin D 57 lanthanum carbonate 57 HER2 overexpression 57 blood phenylalanine Phe 57 urate 57 logistic regression analysis 57 prothrombin 57 alanine transaminase 57 triglyceride 57 Celecoxib 57 cholinergic tone 57 echocardiographic parameters 57 QT intervals 57 cerebral oxygen saturation 57 sotalol 57 retinol binding protein 57 rimonabant #mg 57 antidiabetic medication 57 oral antidiabetes 57 urinary calcium excretion 57 antioxidative 57 fluvastatin 57 nonobstructive CAD 57 serum IgG 57 ascorbate 57 cardioprotective effects 57 renal excretion 57 Crohn Disease Activity 57 Lantus ® 57 cellularity 57 hemodynamic parameters 57 antihypertensive medication 57 Triglyceride 57 insulin sensitization 57 PASI scores 57 postprandial 57 serum testosterone levels 57 pathophysiological mechanisms 57 lymphopenia 57 STN stimulation 57 antigen PSA levels 57 activin 57 plasma glucose concentration

Back to home page